Publication | Open Access
Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
34
Citations
19
References
2017
Year
Low-dose RTX therapy is effective and safe in immunosuppression-resistant IMN.
| Year | Citations | |
|---|---|---|
Page 1
Page 1